abstract |
FIELD: biotechnology. n SUBSTANCE: invention refers to producing a molecule specifically bound to HBsAg, CD3 and CD28, and can be used in medicine. n EFFECT: obtained binding molecule consists of two polypeptides with SEQ ID NO: 43 and SEQ ID NO: 44, interconnected by leucine zipper, and can be used for effective treatment or prevention of HVB infection or condition caused by said HVB infection. n 4 cl, 9 dwg, 4 ex |